10:05 am Expected IPO Pricings Jan 26 - Jan 30
The following IPO's are expected to price and begin trading next week:
Wednesday, January 28
- Presbia (:LENS): The ophthalmic device company developing an implantable optical lens for treating presbyopia is expected to price its 4.2 million share IPO between $11-13. Lead underwriters on the deal are Deutsche Bank, Citigroup, JP Morgan, and Morgan Stanley.
- Zosana Pharma (ZSAN): The clinical-stage pharma developing a transdermal micro-needle patch system to deliver formulations of existing drugs is expected to price its 3.0 million …More